Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nefazodone hydrochloride 100 mg oral tablet |
Is a |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 200 mg oral tablet |
Is a |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 50mg+100mg+200mg initiation tablet pack |
Is a |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 50mg+100mg+200mg initiation tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nefazodone hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nefazodone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nefazodone hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nefazodone hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nefazodone hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 100 mg oral tablet |
Has precise active ingredient |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 50 mg oral tablet |
Has precise active ingredient |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 200 mg oral tablet |
Has precise active ingredient |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 150 mg oral tablet |
Has precise active ingredient |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nefazodone hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nefazodone hydrochloride 300 mg oral tablet |
Has precise active ingredient |
True |
Nefazodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |